Drug Shortage Report for LEVOFLOXACIN IN 5% DEXTROSE INJECTION
Report ID | 189581 |
Drug Identification Number | 02314932 |
Brand name | LEVOFLOXACIN IN 5% DEXTROSE INJECTION |
Common or Proper name | LEVOFLOXACIN IN 5% DEXTROSE INJECTION |
Company Name | PFIZER CANADA ULC |
Market Status | MARKETED |
Active Ingredient(s) | LEVOFLOXACIN |
Strength(s) | 5MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 24 x 150mL bag |
ATC code | J01MA |
ATC description | QUINOLONE ANTIBACTERIALS |
Reason for shortage | Shortage of an inactive ingredient or component. |
Anticipated start date | |
Actual start date | 2023-06-19 |
Estimated end date | |
Actual end date | 2023-11-22 |
Shortage status | Resolved |
Updated date | 2023-11-23 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v12 | 2023-11-23 | French | Compare |
v11 | 2023-11-23 | English | Compare |
v10 | 2023-09-13 | French | Compare |
v9 | 2023-09-13 | English | Compare |
v8 | 2023-07-26 | French | Compare |
v7 | 2023-07-26 | English | Compare |
v6 | 2023-06-20 | English | Compare |
v5 | 2023-06-19 | French | Compare |
v4 | 2023-06-19 | English | Compare |
v3 | 2023-06-10 | English | Compare |
v2 | 2023-04-14 | French | Compare |
v1 | 2023-04-14 | English | Compare |
Showing 1 to 12 of 12